<code id='797E236EB5'></code><style id='797E236EB5'></style>
    • <acronym id='797E236EB5'></acronym>
      <center id='797E236EB5'><center id='797E236EB5'><tfoot id='797E236EB5'></tfoot></center><abbr id='797E236EB5'><dir id='797E236EB5'><tfoot id='797E236EB5'></tfoot><noframes id='797E236EB5'>

    • <optgroup id='797E236EB5'><strike id='797E236EB5'><sup id='797E236EB5'></sup></strike><code id='797E236EB5'></code></optgroup>
        1. <b id='797E236EB5'><label id='797E236EB5'><select id='797E236EB5'><dt id='797E236EB5'><span id='797E236EB5'></span></dt></select></label></b><u id='797E236EB5'></u>
          <i id='797E236EB5'><strike id='797E236EB5'><tt id='797E236EB5'><pre id='797E236EB5'></pre></tt></strike></i>

          fashion

          Wikipedia

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves
          Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

          MollyFerguson/STATThisweek,anencouragingturnaroundforOcularTherapeutix,achatwithAlnylam’sCEOdefendin

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          After decades in use, heart stents finally beat placebo

          AdobePHILADELPHIA—Anewstudy,andthebolddoctorwholedit,couldresultinbigquestionsabouthowresearchersstu